Sensydia Corporation

About Sensydia Corporation

Sensydia Corporation is a medical technology company focused on developing a non-invasive platform for hemodynamic monitoring. The company's core product is the Cardiac Performance System (CPS), a portable, point-of-care device designed for the rapid assessment of critical care and heart failure patients.

The CPS utilizes proprietary sensor technology and machine learning algorithms to analyze heart sounds and provide key hemodynamic metrics. This approach aims to offer a safer and faster alternative to traditional, more invasive methods, potentially reducing the need for repeated echocardiograms.

The company targets the healthcare sector, specifically clinicians managing patients with cardiovascular diseases. By providing immediate and accurate data, the system is intended to help guide treatment decisions for patients in critical conditions.

Sensydia has secured funding to advance the development and evaluation of its CPS platform, including an $8 million financing round and a Fast-Track STTR grant from the NIH.